Results 11 to 20 of about 283,602 (288)

Kinetics of severe acute respiratory syndrome coronavirus 2 infection antibody responses

open access: yesFrontiers in Immunology, 2022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly throughout the world, causing severe morbidity and mortality. Since the first reports of Coronavirus disease 2019 (COVID-19) in late 2019, research on the characteristics of ...
Yajie Lin   +7 more
doaj   +1 more source

Humoral Immunity vs. Salmonella

open access: yesFrontiers in Immunology, 2020
In primary infection with Salmonella, it has been reported—without consideration of Salmonella's functions—that humoral immunity plays no role in the clearance of bacteria.
Akiko Takaya   +2 more
doaj   +1 more source

Immune correlates of protection following Rift Valley fever virus vaccination

open access: yesnpj Vaccines, 2022
Rift Valley fever virus (RVFV) is a hemorrhagic fever virus with the potential for significant economic and public health impact. Vaccination with an attenuated strain, DelNSsRVFV, provides protection from an otherwise lethal RVFV challenge, but ...
Joshua D. Doyle   +3 more
doaj   +1 more source

COVID-19 Outcomes in Patients Undergoing B Cell Depletion Therapy and Those with Humoral Immunodeficiency States: A Scoping Review

open access: yesPathogens and Immunity, 2021
Background: The role of humoral immunity has been well established in reducing infection risk and facilitating viral clearance in patients with COVID-19. However, the relationship between specific antibody responses and severity of COVID-19 is less well
Jessica Jones   +4 more
doaj   +1 more source

Influenza and memory T cells : how to awake the force [PDF]

open access: yes, 2016
Annual influenza vaccination is an effective way to prevent human influenza. Current vaccines are mainly focused on eliciting a strain-matched humoral immune response, requiring yearly updates, and do not provide protection for all vaccinated individuals.
Glezen   +12 more
core   +3 more sources

Comparison of the humoral and cellular immunity in COVID-19 convalescents

open access: yesИнфекция и иммунитет, 2022
The SARS-CoV-2 virus caused the COVID-19 pandemic is related to the SARS-CoV-1 and MERS coronaviruses, which were resulted in 2003 and 2012 epidemics. Antibodies in patients with COVID-19 emerge 714 days after the onset of symptoms and gradually increase.
Anna P. Toptygina   +3 more
doaj   +1 more source

Reviewing the effects of food provisioning on wildlife immunity [PDF]

open access: yes, 2018
While urban expansion increasingly encroaches on natural habitats, many wildlife species capitalize on anthropogenic food resources, which have the potential to both positively and negatively influence their responses to infection.
Babayan, Simon A.   +2 more
core   +1 more source

Circumventing antivector immunity: potential use of nonhuman adenoviral vectors [PDF]

open access: yes, 2014
Adenoviruses are efficient gene delivery vectors based on their ability to transduce a wide variety of cell types and drive high-level transient transgene expression. While there have been advances in modifying human adenoviral (HAdV) vectors to increase
Beard C.W.   +30 more
core   +3 more sources

Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity

open access: yesCell Reports, 2018
Human high-affinity antibodies to pathogens often recognize unrelated ligands. The molecular origin and the role of this polyreactivity are largely unknown.
Julie Prigent   +14 more
doaj   +1 more source

Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex

open access: yesScientific Reports, 2022
The lipid nanoparticle (LNP)-formulated mRNA vaccines BNT162b2 and mRNA-1273 are a widely adopted multi vaccination public health strategy to manage the COVID-19 pandemic. Clinical trial data has described the immunogenicity of the vaccine, albeit within
Chapin S. Korosec   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy